NICE technology appraisal guidance
Issued: October 2002
TA52
Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta52
Important information about this guidance
In January 2006, following consultation, the Institute decided to make this guidance 'static.' This means that the guidance remains in force and has no scheduled review date. See the review decision, under 'Background information' (www.nice.org.uk/guidance/TA52), for further details.